Share on LinkedInShare on LinkedIn

ARTICLE · 27 SEPTEMBER 2018

What Are The Top Hatch-Waxman and BPCIA Developments For August 2018?

Morrison Foerster
Morrison Foerster
Contributor
Morrison Foerster

Morrison Foerster

With approximately 1,000 lawyers in 19 offices, Morrison & Foerster is a preeminent global law firm...

View firm profile
Explore more from Morrison Foerster

This month we highlight a district court opinion from Judge Dyk, sitting by designation, denying a preliminary injunction in a brand-vs-brand litigation...

United StatesIntellectual Property

This month we highlight a district court opinion from Judge Dyk, sitting by designation, denying a preliminary injunction in a brand-vs-brand litigation, and a lengthy district court opinion from Judge Bryson, sitting by designation, addressing joint infringement, inherent anticipation and obviousness, and written description.

CASES

Federal Circuit

PTAB Got Priority Wrong

Otonomy, Inc. v. Auris Medical, AG, 08/01/18 (Fed. Cir. Nos. 2017-1850, 2017-1880)

In this appeal from an interference, the court first held that Auris was not entitled to the benefit of its PCT priority date because the PCT application does not teach the requisite suspension of fluoroquinolone, but rather a dissolved solution.  Moreover, Auris was not entitled to a priority date earlier than the preliminary amendment in which a claim matching the interference count was presented, because there was no written description absent that amendment.  Accordingly, the court reversed the priority

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Morrison & Foerster LLP. All rights reserved

See more popular content from